glutathione oxidase biosensor

glutathione oxidase biosensor A sensitive colorimetric sensor for on the basis of the oxidase-like activity of polyoxometalate-based helical compound and its nanocomposite with SWNT-COOH Sb-doped FeOCl nanozyme-based biosensor for

Name: glutathione oxidase biosensor A sensitive colorimetric sensor for on the basis of the oxidase-like activity of polyoxometalate-based helical compound and its nanocomposite with SWNT-COOH Sb-doped FeOCl nanozyme-based biosensor for
Brand: aimoneimmobiliare.it
SKU: 94935945253
Price: 22.72 USD
Availability: InStock
Rating: 4.1332 (20 reviews)

Sb doped FeOCl nanozyme based biosensor for highly sensitive colorimetric detection of glutathione Analytical and Bioanalytical Chemistry Springer Nature Link Glutathione and biosensor technologies: Enhancing plant resilience to environmental stressors ScienceDirect A locally activatable sensor for robust quantification of organellar glutathione Nature Chemistry Fluorescent Sensing of Glutathione and Related Bio Applications Construction of electrochemiluminescence biosensor for monitoring of glutathione released by living cancer cells ScienceDirect

SKU: 94935945253 · From aimoneimmobiliare.it

4.1

USD22.72 USD56.72

Pay in 4 interest-free payments of $5.68 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

In islet cells, extracellular glucose is transported into the cytoplasm by glucose transporter 2 (GLUT2), where glucose is subsequently phosphorylated by glucokinase (GCK), generating glucose-6-phosphate (G6P)

Danylchenko and Tokarenko, 2014

Hyaluronan in human malignancies

806 A range of advanced technologies are employed to investigate energy metabolism for diagnostic purposes, including blood and urine biochemical assays, spectrometry, bioprobes, magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging, nanotechnology, metabolomics, and techniques such as electrochemistry and sensing (Fig

MTL-CEBPA, a small activating RNA therapeutic upregulating C/EBP-alpha, in patients with advanced liver cancer: a first-in-human, multicenter, open-label, phase I trial